2026 Nobel Prize in Medicine Awarded to Deisseroth, Hegemann, and Nagel for Discoveries Underlying Optogenetics
KEY TAKEAWAYS
- Karl Deisseroth, MD, PhD, Peter Hegemann, PhD, and Georg Nagel, PhD, received the 2026 Nobel Prize in Physiology or Medicine for discoveries concerning light-gated ion channels and optogenetics.
- Optogenetics involves the use of light to control selected nerve cells, allowing researchers to establish causal links between neural circuits and specific memories, emotions, behaviors, and bodily functions.
- Optogenetics remains primarily a neuroscience research tool, but it has helped researchers investigate neural circuits relevant to neurologic and psychiatric disorders, with clinical research also exploring its use to restore vision.
The 2026 Nobel Prize in Physiology or Medicine recognizes discoveries that gave neuroscientists a new way to investigate how specific nerve cells contribute to brain function. The Nobel Assembly at Karolinska Institutet awarded the prize jointly to Karl Deisseroth, MD, PhD, of the Howard Hughes Medical Institute and Stanford University, Stanford, California; Peter Hegemann, PhD, of Humboldt University of Berlin, Germany; and Georg Nagel, PhD, of the University of Würzburg, Germany, for discoveries involving light-gated ion channels and the development of optogenetics.
The work began with Hegemann and Nagel's studies of Chlamydomonas, a single-celled alga that responds to light. In the early 2000s, the researchers discovered channelrhodopsin, a light-sensitive protein that opens an ion channel when illuminated with blue light, allowing charged ions to enter the cell and generate an electrical impulse. They found that introducing the protein into other cells made those cells light sensitive.
Deisseroth subsequently introduced the gene encoding channelrhodopsin into rat neurons and demonstrated in 2005 that blue light could trigger neural signals. By 2007, the approach had been extended to the brains of living mice. The resulting technique, known as optogenetics, enables researchers to manipulate neural activity with light and examine how particular circuits contribute to memories, emotions, behaviors, and other functions.
What This Means for Neurology
- Establishing causality in neural circuits: Earlier approaches could associate brain regions with particular functions, whereas optogenetics allows researchers to selectively control neural activity and investigate the roles of specific circuits.
- Investigating neurologic and psychiatric disease: Researchers have used optogenetics to identify neural circuits involved in memories, emotions, and behaviors relevant to neurologic and psychiatric disorders.
- Clinical translation remains early: Optogenetics is primarily a research methodology rather than a routine clinical tool. The Nobel Assembly highlighted efforts to restore sight in people with visual impairment as one area of clinical investigation.
For practicing neurologists, the immediate relevance is not a new clinical intervention but a research approach that has helped investigators define neural circuits underlying specific functions, behaviors, and disease-relevant processes.
Source
The Nobel Assembly at Karolinska Institutet. The 2026 Nobel Prize in Physiology or Medicine: Light-seeking algae gave us a switch for nerve cells. Press release. Published October 5, 2026. Nobel Prize. https://www.nobelprize.org/prizes/medicine/2026/press-release/